Inter‐laboratory analytical improvement of succinylacetone and nitisinone quantification from dried blood spot samples

BACKGROUND: Nitisinone is used to treat hereditary tyrosinemia type 1 (HT‐1) by preventing accumulation of toxic metabolites, including succinylacetone (SA). Accurate quantification of SA during newborn screening is essential, as is quantification of both SA and nitisinone for disease monitoring and...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:JIMD Rep
Autori principali: Laeremans, Hilde, Turner, Charles, Andersson, Tommy, de Juan, Jose Angel Cocho, Gerrard, Adam, Heiner‐Fokkema, M. Rebecca, Herebian, Diran, Janzen, Nils, la Marca, Giancarlo, Rudebeck, Mattias
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley & Sons, Inc. 2020
Soggetti:
Research Reports
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7203657/
https://ncbi.nlm.nih.gov/pubmed/32395414
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmd2.12112
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi